|
|
|
|
|
|
|
|
abstract:
“It's not if I get cancer, it's when I get cancer”: Previvors' (Un)Certain health experiences regarding hereditary breast and ovarian cancer risk
June 23, 2016
Highlights
- •
- A BReast CAncer (BRCA) genetic mutation increases a patient's cancer risk.
- •
- Interviews were conducted with patients to understand their health experiences.
- •
- BRCA-positive patients experience sources of medical and familial uncertainty.
- •
- BRCA-positive patients experience (un)certainty as an ongoing process.
- •
- This research extends conceptual understandings of uncertainty in health.
Abstract
Rationale
Women with a harmful mutation in the BReast CAncer (BRCA)
gene are at significantly increased risk of developing hereditary
breast and ovarian cancer (HBOC) during their lifetime, compared to
those without. Such patients—with a genetic predisposition to develop
cancer but who have not yet been diagnosed with cancer—live in a
constant state of uncertainty and wonder not if they might get cancer
but when.
Objective
Framed by uncertainty management theory, the purpose of this study was to explore BRCA-positive patients' health experiences after testing positive for the BRCA genetic mutation, specifically identifying their sources of uncertainty.
Methods
Thirty-four,
qualitative interviews were conducted with female patients.
Participants responded to online research postings on the non-profit
organization Facing Our Risk of Cancer Empowered's (FORCE) message board
and social media pages as well as HBOC-specific Facebook groups. The
interview data were coded using the constant comparison method.
Results
Two major themes representing BRCA-positive
patients' sources of uncertainty regarding their genetic predisposition
and health experiences emerged from the data. Medical uncertainty
included the following three subthemes: the unknown future, medical
appointments, and personal cancer scares. Familial uncertainty
encompassed the subthemes traumatic family cancer memories and
motherhood.
Conclusions
Overall, the study supports and extends existing research on uncertainty—revealing uncertainty is inherent in BRCA-positive patients' health experiences—and offers new insight regarding uncertainty management and HBOC risk.
- (Note) This manuscript is a part of research I conducted for my dissertation at Texas A&M University. My dissertation advisor, listed on the IRB Approval Letter, was Dr. Richard L. Street Jr.
Next phase: which cancer is the next cancer?
ReplyDelete